Clinical outcomes of everolimus-eluting bioresorbable scaffolds or everolimus-eluting stents in patients with acute myocardial infarction: two-year results of the randomised ISAR-Absorb MI trial

被引：3

作者：

Wiebe, Jens ^{[1
,2
]}

Byrne, Robert A. ^{[3
,4
]}

Alfonso, Fernando ^{[5
]}

Maeng, Michael ^{[6
]}

Bradaric, Christian ^{[7
]}

Kretov, Evgeny ^{[8
]}

Cuesta, Javier ^{[5
]}

Kuna, Constantin ^{[1
]}

Ibrahim, Tareq ^{[7
]}

Rivero, Fernando ^{[5
]}

Heugl, Mira ^{[1
]}

Christiansen, Evald H. ^{[6
]}

Joner, Michael ^{[1
,2
]}

Schunkert, Heribert ^{[1
,2
]}

Laugwitz, Karl-Ludwig ^{[2
]}

Kastrati, Adnan ^{[1
,2
]}

Cassese, Salvatore ^{[1
]}

机构：

[1] Tech Univ Munich, Dept Cardiol, Deutsch Herzzentrum Munchen, Munich, Germany

[2] DZHK, German Ctr Cardiovasc Res, Partner site Munich Heart Alliance, Munich, Germany

[3] Mater Private Hosp, Cardiovasc Res, Dublin, Ireland

[4] RCSI Univ Med & Hlth Sci, Sch Pharm & Biomol Sci, Dublin, Ireland

[5] Hosp Univ de La Princesa Madrid, Dept Cardiac, Madrid, Spain

[6] Aarhus Univ Hosp, Dept Cardiol, Aarhus, Denmark

[7] Tech Univ Munich, Klinikum Rechts Isar, Clin & Policlin Internal Med 1, Cardiol & Angiol, Munich, Germany

[8] EN Meshalkin Natl Med Res Ctr, Novosibirsk, Russia

来源：

EUROINTERVENTION | 2022年 / 17卷 / 16期

关键词：

D O I：

10.4244/EIJ-D-21-00653

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1348 / +

页数：6

共 50 条

[1] Everolimus-Eluting Bioresorbable Scaffolds Versus Drug-Eluting Stents in Patients With Acute Myocardial Infarction: 2-Year Results of the Randomized ISAR-Absorb MI Trial
Wiebe, Jens
Schneider, Simon
Cassese, Salvatore
Rai, Himanshu
Hoppmann, Petra
Colleran, Roisin
Alfonso, Fernando
Maeng, Michael
Kretov, Evgeny
Joner, Michael
Laugwitz, Karl-Ludwig
Kastrati, Adnan
Byrne, Robert
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (13) : B11 - B11
[2] Angiographic and clinical outcomes of patients treated with everolimus-eluting bioresorbable stents in routine clinical practice: Results of the ISAR-ABSORB registry
Hoppmann, P.
Kufner, S.
Cassese, S.
Wiebe, J.
Schneider, S.
Pinieck, S.
Scheler, L.
Bernlochner, I.
Joner, M.
Schunkert, H.
Laugwitz, K-L.
Kastrati, A.
Byrne, R. A.
[J]. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2016, 87 (05) : 822 - 829
[3] Long-term clinical outcomes of everolimus-eluting bioresorbable scaffolds versus everolimus-eluting stents: final five-year results of the AIDA randomised clinical trial
Kerkmeijer, Laura S. M.
Renkens, Mick P. L.
Tijssen, Ruben Y. G.
Hofma, Sjoerd H.
van der Schaaf, Rene J.
Arkenbout, E. Karin
Weevers, Auke P. J. D.
Garcia-Garcia, Hector M.
Kraak, Robin
Piek, Jan J.
Tijssen, Jan G. P.
Henriques, Jose P. S.
de Winter, Robbert J.
Wykrzykowska, Joanna J.
[J]. EUROINTERVENTION, 2022, 17 (16) : 1340 - +
[4] Bioresorbable scaffolds versus everolimus-eluting metallic stents: five-year clinical outcomes of the randomised ABSORB II trial
Onuma, Yoshinobu
Chevalier, Bernard
Ono, Masafumi
Cequier, Angel
Dudek, Dariusz
Haude, Michael
Carrie, Didier
Sabate, Manel
Windecker, Stephan
Rapoza, Richard
West, Nick E. J.
Reith, Sebastian
Almeida, Manuel de Sousa
Campo, Gianluca
Iniguez, Andres
Serruys, Patrick W.
[J]. EUROINTERVENTION, 2020, 16 (11) : E938 - E941
[5] A randomized trial evaluating everolimus-eluting Absorb bioresorbable scaffolds vs. everolimus-eluting metallic stents in patients with coronary artery disease: ABSORB Japan
Kimura, Takeshi
Kozuma, Ken
Tanabe, Kengo
Nakamura, Sunao
Yamane, Masahisa
Muramatsu, Toshiya
Saito, Shigeru
Yajima, Junji
Hagiwara, Nobuhisa
Mitsudo, Kazuaki
Popma, Jeffrey J.
Serruys, Patrick W.
Onuma, Yoshinobu
Ying, Shihwa
Cao, Sherry
Staehr, Peter
Cheong, Wai-Fung
Kusano, Hajime
Stone, Gregg W.
[J]. EUROPEAN HEART JOURNAL, 2015, 36 (47) : 3332 - 3342
[6] Prospective, randomized trial of bioresorbable scaffolds vs. everolimus-eluting stents in patients undergoing coronary stenting for myocardial infarction: the Intracoronary Scaffold Assessment a Randomized evaluation of Absorb in Myocardial Infarction (ISAR-Absorb MI) trial
Byrne, Robert A.
Alfonso, Fernando
Schneider, Simon
Maeng, Michael
Wiebe, Jens
Kretov, Evgeny
Bradaric, Christian
Rai, Himanshu
Cuesta, Javier
Rivero, Fernando
Hoppmann, Petra
Schlichtenmaier, Jana
Christiansen, Evald H.
Cassese, Salvatore
Joner, Michael
Schunkert, Heribert
Laugwitz, Karl-Ludwig
Kastrati, Adnan
[J]. EUROPEAN HEART JOURNAL, 2019, 40 (02) : 167 - 176
[7] Comparison of everolimus- and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds: Two-year clinical outcomes of the EVERBIO II trial
Arroyo, Diego
Gendre, Gregoire
Schukraft, Sara
Kallinikou, Zacharenia
Mueller, Olivier
Baeriswyl, Gerard
Stauffer, Jean-Christophe
Goy, Jean-Jacques
Togni, Mario
Cook, Stephane
Puricel, Serban
[J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 243 : 121 - 125
[8] Long-Term Clinical Outcomes of Patients Treated With Everolimus-Eluting Bioresorbable Stents in Routine Practice 2-Year Results of the ISAR-ABSORB Registry
Wiebe, Jens
Hoppmann, Petra
Colleran, Roisin
Kufner, Sebastian
Valeskini, Michael
Cassese, Salvatore
Schneider, Simon
Joner, Michael
Schunkert, Heribert
Laugwitz, Karl-Ludwig
Kastrati, Adnan
Byrne, Robert A.
[J]. JACC-CARDIOVASCULAR INTERVENTIONS, 2017, 10 (12) : 1222 - 1229
[9] 3-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Coronary Scaffolds The ABSORB III Trial
Kereiakes, Dean J.
Ellis, Stephen G.
Metzger, Christopher
Caputo, Ronald P.
Rizik, David G.
Teirstein, Paul S.
Litt, Marc R.
Kini, Annapoorna
Kabour, Ameer
Marx, Steven O.
Popma, Jeffrey J.
McGreevy, Robert
Zhang, Zhen
Simonton, Charles
Stone, Gregg W.
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (23) : 2852 - 2862
[10] Five-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Scaffolds: Results From the Randomized ABSORB II Trial
Serruys, Patrick
Chevalier, Bernard
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (13) : B27 - B27

← 1 2 3 4 5 →